Certis Oncology Solutions
Peter Ellman is the President and CEO of Certis Oncology Solutions, a precision oncology and translational science start-up established in 2016 and located in San Diego, California.
A serial entrepreneur, prior to his current role Peter led Paradox Dx, a pharmacogenomics business and Nextec Applications, an advanced materials technology company. He served on the board of StrataGene, a publicly held molecular diagnostics company acquired by Agilent in 2007. He also served as founding sales executive for Thermoscan, the world’s first infra-red ear thermometer acquired by Gillette in 2003 and Interplak, an electronic consumer products company acquired by Bausch and Lomb in 1988.
Certis Oncology Solutions
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized precision patient care.